Taiwan could buy the COVID-19 vaccine Oxford University is developing with British drugmaker AstraZeneca, a second vaccine showing promising results that the nation will be able to acquire through the COVAX allocation platform, a Central Epidemic Command Center (CECC) official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
South Africa backs off Taiwan office removal deadline, talks ongoing
11/26/2024 05:18 PM - Politics
Five NT$10 billion funds for AI, health tech, green growth on tap
11/26/2024 04:26 PM - Business
U.S. dollar closes higher on Taipei forex market
11/26/2024 04:14 PM - Business
Taiwan shares close down 1.17%
11/26/2024 01:56 PM - Business
Equipment installation begins at TSMC's 2nm Kaohsiung fab
11/26/2024 12:05 PM